HOME >> MEDICINE >> NEWS
FDA grants accelerated approval of TYSABRI, formerly antegren, for the treatment of MS

Phase III trials at one year demonstrate new level of efficacy 66% reduction in rate of relapses seen in AFFIRM monotherapy trial

Cambridge, MA; San Diego, CA; Dublin, Ireland November 23, 2004 Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that the U.S. Food and Drug Administration (FDA) has approved TYSABRI (natalizumab), formerly referred to as ANTEGREN, as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses. FDA granted Accelerated Approval for TYSABRI following Priority Review based on one-year data from two Phase III studies, the AFFIRM monotherapy trial and the SENTINEL add-on trial with AVONEX(Interferon beta-1a).

TYSABRI, the first humanized monoclonal antibody approved for the treatment of MS, inhibits adhesion molecules on the surface of immune cells. Research suggests TYSABRI works by preventing immune cells from migrating from the bloodstream into the brain where they can cause inflammation and potentially damage nerve fibers and their insulation.

"TYSABRI is a powerful and innovative therapy that offers new hope for hundreds of thousands of people living with MS," said James C. Mullen, chief executive officer, Biogen Idec. "We believe TYSABRI will revolutionize the treatment of MS and become the leading choice for patients and physicians."

"TYSABRI is a significant breakthrough for patients with MS," said Kelly Martin, president and chief executive officer, Elan. "The approval of TYSABRI, with its unique mechanism of action and new level of efficacy, has the potential to make a genuine difference in the lives of patients and families who struggle with the debilitating effects of this disease."

Results of the AFFIRM Monotherapy Trial

AFFIRM is a two-year, randomized, multi-center, placebo-controlled, double-blind study of 942 patients conducted in 99 sites worldwide, in which patients were
'"/>

Contact: Amy Losak
646-935-9317
Ketchum
23-Nov-2004


Page: 1 2 3 4 5 6

Related medicine news :

1. UNH launches 2nd spinout company with NIH grants
2. Disease testing for immigrants: Discrimination disguised as public health policy
3. US FDA grants full approval to DOXIL(R) following submission of phase III data
4. Four teams awarded inaugural translational cancer research grants
5. Immigrants, beware: Living in the United States is fattening
6. Prevalence of obesity among immigrants increases with longer residency in US
7. Dana-Farber receives CDC grants to develop health promotion/prevention programs in the work place
8. Speech recognition experts at OGI School of Science & Engineering receive nearly $700,000 in grants
9. Should compulsory screening of immigrants be part of UK public health policy?
10. NIH grants support health disparities biomedical research
11. NCCAM awards planning grants for International Centers for Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... AdventHealth Carrollwood has partnered ... reopening for class on Monday, August 12, 2020. AdventHealth provided the school with key ... COVID-19 in the classroom setting. , “We are taking extra steps in our ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... of consciousness, seizures, prolonged length of hospital stay, or even death. A researcher ... insulin-treated patients with Type 2 diabetes to see if the use of continuous ...
(Date:8/5/2020)... EVANSTON, Ill. (PRWEB) , ... August 05, 2020 ... ... leader in the animal health industry, as president of the largest veterinarian-owned purchasing ... at CEVA SANTE ANIMALE in various roles where she gained extensive knowledge and ...
(Date:8/5/2020)... Africa (PRWEB) , ... August 05, 2020 , ... Today, ... Africa , the leading trade and investment platform for Africa, announced that they have ... for YPO Africa and Invest Africa to support each other in their African impact ...
(Date:8/5/2020)... ... August 04, 2020 , ... ... with memory impairment, has announced the Best Memory Care Facilities in Austin, Texas. ... facility features and amenities. , According to the Alzheimer’s Association , ...
Breaking Medicine News(10 mins):
(Date:8/5/2020)... , ... August 04, 2020 , ... ... pathology therapy services vital to their health and quality of life unless Congress ... the American Speech-Language-Hearing Association (ASHA) warns today. , At issue ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... is pleased to welcome Michelle Kopronica as their new Vice President of Client ... of practice management knowledge in leading and developing teams and delivering client-focused solutions. ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... Emergency Operations Planning services for small business owners. These plans help ... manage or communicate with their teams for 30-90 days as a result of ...
Breaking Medicine Technology:
Cached News: